The adjacent vessel sign on breast MRI: new data and a subgroup analysis for 1,084 histologically verified cases
- PMID: 20191065
- PMCID: PMC2827781
- DOI: 10.3348/kjr.2010.11.2.178
The adjacent vessel sign on breast MRI: new data and a subgroup analysis for 1,084 histologically verified cases
Abstract
Objective: The adjacent vessel sign (AVS) is a descriptor for differentiating malignant from benign breast lesions on breast MRI (bMRI). This investigation was designed to verify the previous reports on the diagnostic accuracy of AVS and to assess correlation between AVS, histopathological diagnosis, lesion size and lesion grade.
Materials and methods: This study was approved by the local ethical committee. Experienced radiologists evaluated 1,084 lesions. The exclusion criteria were no histological verification after bMRI and breast interventions that were done up to one year before bMRI (surgery, core biopsy, chemo- or radiation therapy). The native and dynamic contrast-enhanced T1-weighted series were acquired using standardized protocols. The AVS was rated positive if a vessel leading to a lesion could be visualized. Prevalence of an AVS was correlated with the lesions' size, grade and histology using Chi-square-tests.
Results: The AVS was significantly associated with malignancy (p < 0.001; sensitivity: 47%, specificity: 88%, positive-predictive-value [PPV]: 85%). Malignant lesions > 2 cm more often presented with an AVS than did those malignant lesions < 2 cm (p < 0.0001; sensitivity: 65%, PPV: 90%). There was no correlation of the AVS with the tumor grade. The prevalence of an AVS didn't significantly differ between invasive lobular carcinomas versus ductal carcinomas. In situ cancers were less frequently associated with an AVS (p < 0.001).
Conclusion: The adjacent vessel sign was significantly associated with malignancy. Thus, it can be used to accurately assess breast lesions on bMRI. In this study, the AVS was particularly associated with advanced and invasive carcinomas.
Keywords: Breast, MR; Contrast media; Descriptor; Histology; Neoangiogenesis; Sign.
Figures






Similar articles
-
The potential of predictive and prognostic breast MRI (P2-bMRI).Eur Radiol Exp. 2022 Aug 22;6(1):42. doi: 10.1186/s41747-022-00291-z. Eur Radiol Exp. 2022. PMID: 35989400 Free PMC article. Review.
-
The hook sign for differential diagnosis of malignant from benign lesions in magnetic resonance mammography: experience in a study of 1084 histologically verified cases.Acta Radiol. 2010 Mar;51(2):137-43. doi: 10.3109/02841850903463638. Acta Radiol. 2010. PMID: 20092368
-
The necrosis sign in magnetic resonance-mammography: diagnostic accuracy in 1,084 histologically verified breast lesions.Breast J. 2010 Nov-Dec;16(6):603-8. doi: 10.1111/j.1524-4741.2010.00982.x. Breast J. 2010. PMID: 21070437
-
Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.Magn Reson Med Sci. 2010;9(4):217-25. doi: 10.2463/mrms.9.217. Magn Reson Med Sci. 2010. PMID: 21187691
-
How to use the Kaiser score as a clinical decision rule for diagnosis in multiparametric breast MRI: a pictorial essay.Insights Imaging. 2018 Jun;9(3):325-335. doi: 10.1007/s13244-018-0611-8. Epub 2018 Apr 3. Insights Imaging. 2018. PMID: 29616496 Free PMC article. Review.
Cited by
-
Bilateral analysis of the cross-sectional area of the internal mammary arteries and veins in patients with and without breast cancer on breast magnetic resonance imaging.Insights Imaging. 2013 Apr;4(2):177-84. doi: 10.1007/s13244-012-0214-8. Epub 2013 Jan 16. Insights Imaging. 2013. PMID: 23322271 Free PMC article.
-
Differential diagnosis of plasma cell mastitis and invasive ductal carcinoma using multiparametric MRI.Gland Surg. 2020 Apr;9(2):278-290. doi: 10.21037/gs.2020.03.30. Gland Surg. 2020. PMID: 32420252 Free PMC article.
-
The value of adjacent vessel sign in malignant breast tumors.Diagn Interv Radiol. 2022 Sep;28(5):463-469. doi: 10.5152/dir.2022.211228. Diagn Interv Radiol. 2022. PMID: 35997479 Free PMC article.
-
A simple and robust classification tree for differentiation between benign and malignant lesions in MR-mammography.Eur Radiol. 2013 Aug;23(8):2051-60. doi: 10.1007/s00330-013-2804-3. Epub 2013 Apr 12. Eur Radiol. 2013. PMID: 23579418
-
The potential of predictive and prognostic breast MRI (P2-bMRI).Eur Radiol Exp. 2022 Aug 22;6(1):42. doi: 10.1186/s41747-022-00291-z. Eur Radiol Exp. 2022. PMID: 35989400 Free PMC article. Review.
References
-
- Fischer DR, Malich A, Wurdinger S, Boettcher J, Dietzel M, Kaiser WA. The adjacent vessel on dynamic contrast-enhanced breast MRI. AJR Am J Roentgenol. 2006;187:W147–W151. - PubMed
-
- Fischer DR, Wurdinger S, Boettcher J, Malich A, Kaiser WA. Further signs in the evaluation of magnetic resonance mammography: a retrospective study. Invest Radiol. 2005;40:430–435. - PubMed
-
- Malich A, Fischer DR, Wurdinger S, Boettcher J, Marx C, Facius M, et al. Potential MRI interpretation model: differentiation of benign from malignant breast masses. AJR Am J Roentgenol. 2005;185:964–970. - PubMed
-
- Peters NH, Borel Rinkes IH, Zuithoff NP, Mali WP, Moons KG, Peeters PH. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology. 2008;246:116–124. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical